295 related articles for article (PubMed ID: 15989140)
1. Role of metabolism in drug-induced idiosyncratic hepatotoxicity.
Walgren JL; Mitchell MD; Thompson DC
Crit Rev Toxicol; 2005; 35(4):325-61. PubMed ID: 15989140
[TBL] [Abstract][Full Text] [Related]
2. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.
Thompson RA; Isin EM; Ogese MO; Mettetal JT; Williams DP
Chem Res Toxicol; 2016 Apr; 29(4):505-33. PubMed ID: 26735163
[TBL] [Abstract][Full Text] [Related]
3. Idiosyncratic drug hepatotoxicity.
Kaplowitz N
Nat Rev Drug Discov; 2005 Jun; 4(6):489-99. PubMed ID: 15931258
[TBL] [Abstract][Full Text] [Related]
4. Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.
Cosgrove BD; King BM; Hasan MA; Alexopoulos LG; Farazi PA; Hendriks BS; Griffith LG; Sorger PK; Tidor B; Xu JJ; Lauffenburger DA
Toxicol Appl Pharmacol; 2009 Jun; 237(3):317-30. PubMed ID: 19362101
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inhibition of CYP450: an indicator of drug-induced hepatotoxicity.
Feng S; He X
Curr Drug Metab; 2013 Nov; 14(9):921-45. PubMed ID: 24016115
[TBL] [Abstract][Full Text] [Related]
6. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages.
Giri S; Nieber K; Bader A
Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):895-917. PubMed ID: 20367107
[TBL] [Abstract][Full Text] [Related]
7. [Reactive metabolites of xenobiotics : their role in the hepatotoxicity of drugs].
Pessayre D; Benhamou JP
C R Seances Soc Biol Fil; 1979; 173(2):458-68. PubMed ID: 159767
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activation in drug-induced liver injury.
Leung L; Kalgutkar AS; Obach RS
Drug Metab Rev; 2012 Feb; 44(1):18-33. PubMed ID: 21939431
[TBL] [Abstract][Full Text] [Related]
9. Hepatotoxicity by Drugs: The Most Common Implicated Agents.
Björnsson ES
Int J Mol Sci; 2016 Feb; 17(2):224. PubMed ID: 26861310
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of which reactive metabolite, if any, is responsible for a specific idiosyncratic reaction.
Uetrecht J
Drug Metab Rev; 2006; 38(4):745-53. PubMed ID: 17145699
[TBL] [Abstract][Full Text] [Related]
11. Computational chemistry approach for the early detection of drug-induced idiosyncratic liver toxicity.
Cruz-Monteagudo M; Cordeiro MN; Borges F
J Comput Chem; 2008 Mar; 29(4):533-49. PubMed ID: 17705164
[TBL] [Abstract][Full Text] [Related]
12. Idiosyncratic drug reactions: possible role of reactive metabolites generated by leukocytes.
Uetrecht JP
Pharm Res; 1989 Apr; 6(4):265-73. PubMed ID: 2664753
[TBL] [Abstract][Full Text] [Related]
13. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.
Lammert C; Einarsson S; Saha C; Niklasson A; Bjornsson E; Chalasani N
Hepatology; 2008 Jun; 47(6):2003-9. PubMed ID: 18454504
[TBL] [Abstract][Full Text] [Related]
14. Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science.
Antoine DJ; Williams DP; Park BK
Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1415-27. PubMed ID: 18950283
[TBL] [Abstract][Full Text] [Related]
15. Drug reactive metabolite-induced hepatotoxicity: a comprehensive review.
Mahajan P; Palkar M; Pingili RB
Toxicol Mech Methods; 2024 Jul; 34(6):607-627. PubMed ID: 38504503
[TBL] [Abstract][Full Text] [Related]
16. Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions?
Uetrecht JP
Curr Drug Metab; 2000 Sep; 1(2):133-41. PubMed ID: 11465079
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of potential hepatotoxicity induced by drugs.
Gómez-Lechón MJ; Lahoz A; Gombau L; Castell JV; Donato MT
Curr Pharm Des; 2010 Jun; 16(17):1963-77. PubMed ID: 20236064
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system.
Ju C; Uetrecht JP
Curr Drug Metab; 2002 Aug; 3(4):367-77. PubMed ID: 12093356
[TBL] [Abstract][Full Text] [Related]
19. A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity.
Li AP
Chem Biol Interact; 2002 Nov; 142(1-2):7-23. PubMed ID: 12399152
[TBL] [Abstract][Full Text] [Related]
20. Are chemically reactive metabolites responsible for adverse reactions to drugs?
Williams DP; Kitteringham NR; Naisbitt DJ; Pirmohamed M; Smith DA; Park BK
Curr Drug Metab; 2002 Aug; 3(4):351-66. PubMed ID: 12093355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
